Dr. Michael B. Ibach, MD

Dr. Ibach practices at Borland Groover Clinic, PA in Jacksonville Beach, Florida.

Dr. Ibach's NPI, 1053362723, was assigned on May 15, 2006. Dr. Ibach graduated from USF Health Morsani College of Medicine in 1989. Dr. Ibach holds Florida license ME67895.

Dr. Ibach's primary practice is Borland Groover Clinic, PA, at 1375 Roberts Dr, Jacksonville Beach, FL 32250 in Duval County. The practice phone is (904) 398-7205.

Dr. Ibach's primary practice is Borland Groover Clinic, PA in Jacksonville Beach, Florida. Dr. Ibach is also affiliated with Baptist Medical Center Beaches. The medical group on file is Borland Groover. Dmand AI also links Dr. Ibach to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibach practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ibach's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Ibach is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ibach's licenses on file in 4 states: Florida, Tennessee, Louisiana and Pennsylvania.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Ibach treats.

CMS data shows 1,346 Medicare services from Dr. Ibach across 16 procedure codes in 2024, for 667 Medicare patients. Medicare paid $135,289 for them.

CMS counts 667 Medicare patients who saw Dr. Ibach in 2024. The largest group is 65 to 74, with 354 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ibach's median patient age at 66, with 53% women.

In 2024, Dr. Ibach wrote 908 Medicare Part D claims for 401 patients. 90% of them were for generic drugs. CMS names the drug for 782 of them, across 19 drugs with 11 or more claims each, at $71,331 in total drug cost. In 2023, CMS named 793 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Ibach for performance year 2024, reported as part of a group. Dr. Ibach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 243 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ibach, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Ibach in 2024. The most frequent topics are Colonoscopy. Dr. Ibach's most frequent co-authors are Indira Bhavsar-Burke, MD, Daniel C. Buckles, MD and Kevin Munish Comar, MD.

CMS Open Payments shows 154 general payments to Dr. Ibach from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Adare Pharmaceuticals, Inc. paid the most, $1,459.

Dmand AI lists 1 award for Dr. Ibach, most recently CMS Stage 1 EHR in 2013.

Dr. Ibach graduated from USF Health Morsani College of Medicine in 1989.

Dr. Ibach is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.